blog

The Impact of COVID-19 on Clinical Trials: Where are We? And Where are We Going?

By Aaron Fleishman, Director, Market Development on Tue, Jun 23, 2020 | 2 min read

 

Get the latest insights from our BBK-sponsored podcast.

As the country goes through the phases of reopening, what does that mean for the patient and site experience in clinical trials? PharmaTalkRadio’s Valerie Bowling discusses the future of clinical trials with Ray Dorsey, MD, Matt Kibby, and Craig Lipset in this feature podcast.

Topics: Clinical Trials, Pharma15 Live!, COVID-19, Matt Kibby, Craig Lipset, Decentralized Trials, Conference Forum

 
Subscribe To Our Blog